Craiglow, Brittany
Lee, Yang Won
Vañó-Galván, Sergio
Egeberg, Alexander
Dutronc, Yves
Durand, Frederick
Pierce, Evangeline
Yu, Guanglei
Chen, Yun-Fei
Mostaghimi, Arash
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 13 March 2024
Accepted: 6 June 2024
First Online: 21 June 2024
Declarations
:
: Brittany Craiglow has received support for medical writing from Eli Lilly; consulting fees from Dermavant, Eli Lilly, Incyte, Pfizer, Concert Pharmaceuticals, Regeneron, Sanofi-Genzyme; payment and/or honoraria from Abbvie, Eli Lilly and Company, Incyte Corporation, Pfizer, Regeneron, and Sanofi Genzyme; support for attending meetings/travel from Eli Lilly and Pfizer; and is a member of the Board of Directors and Medical and Scientific Advisory Board and of the Foundation for Ichthyosis and Related Skin Types. Yang Won Lee has received support for the clinical trial from Eli Lilly and Company. Sergio Vañó‑Galván reports consulting fees and payment/honoraria from Eli Lilly and Company and Pfizer. Alexander Egeberg has received research funding from Abbvie, Danish National Psoriasis Foundation, Eli Lilly, Janssen, Kgl. Hofbundtmager Aage Bangs Foundation, Novartis, Pfizer, Boehringer Ingelheim, Bristol-Myers Squibb, Almirall, Simon Spies Foundation; consulting fees from AbbVie, Almirall, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly and Company, Galapagos NV, Galderma, Janssen, LEO Pharma, Mylan, Novartis, Pfizer, Samsung Bioepis, Boehringer Ingelheim, UCB, UNION Therapeutics, Horizon Therapeutics; payment/honoraria from AbbVie, Almirall, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly and Company, Galderma, Janssen, LEO Pharma, Mylan, Novartis, Pfizer, Samsung Bioepis, UCB; and support for attending congresses from Abbvie, Eli Lilly, Bristol-Myers Squibb, Janssen. He has participated on a data safety monitoring board/advisory boards from Samsung Bioepis and Horizon Therapeutics; and has stock options from LEO Pharma; Alexander Egeberg is an employee of LEO Pharma. Yves Dutronc, Frederick Durand, Evangeline Pierce, Guanglei Yu, and Yun‑Fei Chen are employees and shareholders of Eli Lilly and Company. Arash Mostaghimi has been a consultant for Hims and Hers, Abbvie, Sun Pharmaceuticals, Pfizer, Digital Diagnostics, Aslan, Boehringer Ingelheim, ACOM and Olaplex; received support for materials from Lilly; received royalties for the BELA, BETA, and ALFA scales outside of this work; received payment or honoraria from Lilly; received support for travel from Lilly; and is Secretary/Treasurer for the Medical Dermatology Society.
: The trials were conducted in accordance with the ethical principles of the Declaration of Helsinki of 1964 and its subsequent amendments and with Good Clinical Practice guidelines, and the research protocols were approved by each center’s institutional review board or ethics committee. All patients provided written informed consent for participation in the trials<i>.</i>